Atlas Trials

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Clinical trial NCT00003183 · UNKNOWN

Trial details

NCT number
NCT00003183
Sponsor
Hope Cancer Institute, Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
1997-03-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.